Mechanism of action and novelty: Newer agents with more complex mechanisms such as dual or triple receptor agonists tend to be priced at a premium compared with established treatments
Dulaglutide (Trulicity) has two copies of a GLP-1 analogue covalently linked to an Fc fragment of human IgG4 (22,282)
Rabobank: Its way too early to draw conclusions However, Nick Fereday, senior analyst, consumer foods at Rabobank, says we should be careful about making sweeping predictions about the future of the food industry based on preliminary survey data from a relatively small number of GLP-1 drug users
A new study suggests that individuals taking popular new GLP-1 receptor agonist drugs, such as Ozempic, Wegovy and Mounjaro, face an increased risk of nausea, vomiting and other stomach problems, especially when taking higher doses of the medication